Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hasmukh Jain

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Cancer Immunology, Immunotherapy : CII|February 23, 2026
Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agentManasi Nagare, Monalisa Sahoo, Manju Sengar, et al.
Leukemia & Lymphoma|March 22, 2016
Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistanceNikhil Patkar, Kiran Ghodke, Swapnali Joshi, et al.
Oncotarget|December 20, 2018
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Oncotarget|February 8, 2019
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Leukemia|February 9, 2021
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in IndiaShasanka Das, Bhausaheb Bagal, Hasmukh Jain, et al.
JCO Global Oncology|February 1, 2024
Clinical Utility of Stepwise Bronchoalveolar Lavage Fluid Analysis in Diagnosing and Managing Lung Infiltrates in Leukemia/Lymphoma Patients With Febrile NeutropeniaJayashree Thorat, Surabhi Bhat, Manju Sengar, et al.
Frontiers in Oncology|July 3, 2019
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World ContextNikhil Patkar, Chinmayee Kakirde, Prasanna Bhanshe, et al.
Molecular Cancer Therapeutics|February 26, 2021
Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T CellsAlka Dwivedi, Atharva Karulkar, Sarbari Ghosh, et al.
Leukemia & Lymphoma|August 8, 2020
Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Anam Fatima Shaikh, Chinmayee Kakirde, Chetan Dhamne, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|February 23, 2026
Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agentManasi Nagare, Monalisa Sahoo, Manju Sengar, et al.
Leukemia & Lymphoma|March 22, 2016
Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistanceNikhil Patkar, Kiran Ghodke, Swapnali Joshi, et al.
Oncotarget|December 20, 2018
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Oncotarget|February 8, 2019
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Leukemia|February 9, 2021
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in IndiaShasanka Das, Bhausaheb Bagal, Hasmukh Jain, et al.
JCO Global Oncology|February 1, 2024
Clinical Utility of Stepwise Bronchoalveolar Lavage Fluid Analysis in Diagnosing and Managing Lung Infiltrates in Leukemia/Lymphoma Patients With Febrile NeutropeniaJayashree Thorat, Surabhi Bhat, Manju Sengar, et al.
Frontiers in Oncology|July 3, 2019
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World ContextNikhil Patkar, Chinmayee Kakirde, Prasanna Bhanshe, et al.
Molecular Cancer Therapeutics|February 26, 2021
Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T CellsAlka Dwivedi, Atharva Karulkar, Sarbari Ghosh, et al.
Leukemia & Lymphoma|August 8, 2020
Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Anam Fatima Shaikh, Chinmayee Kakirde, Chetan Dhamne, et al.
Pageof 8